Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Stefan P Glaser, Erinna F Lee, Evelyn Trounson, Philippe Bouillet, Andrew Wei, W Douglas Fairlie, David J Izon, Johannes Zuber, Amy R Rappaport, Marco J Herold, Warren S Alexander, Scott W Lowe, Lorraine Robb, Andreas Strasser
Genes & Development | COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT | Published : 2012
Awarded by NHMRC
Awarded by Leukemia and Lymphoma Society (SCOR)
Awarded by NIH
We thank Drs. L. Hennighausen, J.M. Adams, S. Cory, D. C. S. Huang, M. Cleary, D.-E. Zhang, C. Largman, and M. Busslinger for gifts of mice and retroviral constructs. This work was supported by grants and fellowships from the Deutsche Forschungsgemeinschaft (DFG) (to S. G.), the Lady Tata Memorial Trust (to S. G.), the NHMRC (programs 257500 and 461221; projects 637326 and 1008329; fellowships 356203, 461299, and 575501; and Independent Research Institutes Infrastructure Support Scheme grant 361646), the Leukemia and Lymphoma Society (SCOR grant 7413), the NIH (CA43540 and CA80188), the Victorian Cancer Agency, the Leukemia Foundation of Australia, and the Australian Cancer Research Fund, and by operational infrastructure grants through the Australian Government (IRISS) and the Victorian State Government (OIS).